Clinical Trial Update: Phase IIIb Study of Ribociclib + ET in Early Breast Cancer [Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 3b clinical trial evaluating ribociclib in combination with endocrine therapy for early-stage breast cancer, with status c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Early Breast Cancer | Phase 3 | Status: RECRUITING